HIV Central

W. David Hardy, MD, scientific and medical consultant, and adjunct professor of medicine in the division of infectious diseases at Johns Hopkins University School of Medicine, shared some important take-aways for clinicians from this year’s International AIDS Conference with Healio.

Healio spoke with Rajesh T. Gandhi, MD, of Massachusetts General Hospital and Harvard Medical School, about the benefits and drawbacks of injectable HIV regimens.

Judith Feinberg, MD, from West Virginia University School of Medicine, spoke with Healio about important FDA approvals in HIV, the burden of drug resistance, threats to HIV control and the future of HIV treatment.

Although there have been significant advances in treatment since the start of the HIV/AIDS epidemic, pregnant women have about half as many treatment options as other adults with HIV, Monica Gandhi, MD, MPH, from the University of California, San Francisco, reported at CROI 2019.

Healio spoke with Douglas Krakower, MD, from Beth Israel Deaconess Medical Center, about increasing the use of PrEP, potential downsides to the medication, a newly approved drug to reduce HIV infection and the future of HIV prevention.

Infectious Disease News Chief Medical Editor Paul A. Volberding, MD, spoke with Healio about which types of cancer patients with HIV are more likely to develop, how HIV treatments have changed that risk, how cancer affects HIV treatment and how to increase cancer treatment among these patients.